These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 20819749
1. [Prostanoids in the treatment of pulmonary arterial hypertension]. Başkurt M, Küçükoğlu MS. Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749 [Abstract] [Full Text] [Related]
2. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Gomberg-Maitland M, Olschewski H. Eur Respir J; 2008 Apr; 31(4):891-901. PubMed ID: 18378784 [Abstract] [Full Text] [Related]
3. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Mubarak KK. Respir Med; 2010 Jan; 104(1):9-21. PubMed ID: 19683911 [Abstract] [Full Text] [Related]
4. Inhaled prostanoids in the therapy of pulmonary hypertension. Gessler T, Seeger W, Schmehl T. J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):1-12. PubMed ID: 18518827 [Abstract] [Full Text] [Related]
5. Prostanoid therapy for pulmonary arterial hypertension. Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ. J Am Coll Cardiol; 2004 Jun 16; 43(12 Suppl S):56S-61S. PubMed ID: 15194179 [Abstract] [Full Text] [Related]
6. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Olschewski H, Rose F, Schermuly R, Ghofrani HA, Enke B, Olschewski A, Seeger W. Pharmacol Ther; 2004 May 16; 102(2):139-53. PubMed ID: 15163595 [Abstract] [Full Text] [Related]
7. Prostacyclin therapy for pulmonary arterial hypertension: new directions. Gomberg-Maitland M, Preston IR. Semin Respir Crit Care Med; 2005 Aug 16; 26(4):394-401. PubMed ID: 16121316 [Abstract] [Full Text] [Related]
8. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs. Safdar Z. Respir Med; 2011 Jun 16; 105(6):818-27. PubMed ID: 21273054 [Abstract] [Full Text] [Related]
9. Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension. Theo Schermuly R, Ardeschir Ghofrani H, Weissmann N. Curr Top Dev Biol; 2005 Jun 16; 67():251-84. PubMed ID: 15949537 [Abstract] [Full Text] [Related]
10. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension. John J, Palevsky H. Expert Rev Clin Pharmacol; 2011 Mar 16; 4(2):197-205. PubMed ID: 22115402 [Abstract] [Full Text] [Related]
11. [Treatment of pulmonary hypertension]. Illaro Uranga A, Ibarra Barrueta O, Oribe Ibáñez M, Lertxundi Etxebarría U, Corcostegui Santiago B, Iglesias Lambarri A, Santos Ibáñez A. Farm Hosp; 2004 Mar 16; 28(4):275-85. PubMed ID: 15369438 [Abstract] [Full Text] [Related]
12. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis. Menon N, McAlpine L, Peacock AJ, Madhok R. Arthritis Rheum; 1998 Mar 16; 41(3):466-9. PubMed ID: 9506575 [Abstract] [Full Text] [Related]
13. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis]. Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W. Pneumologie; 2000 Mar 16; 54(3):133-42. PubMed ID: 10783653 [Abstract] [Full Text] [Related]
14. Cellular pathophysiology and therapy of pulmonary hypertension. Olschewski H, Rose F, Grünig E, Ghofrani HA, Walmrath D, Schulz R, Schermuly R, Grimminger F, Seeger W. J Lab Clin Med; 2001 Dec 16; 138(6):367-77. PubMed ID: 11753283 [Abstract] [Full Text] [Related]
19. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost]. Matthes J, Mathen F, Herzig S, Wassermann K. Dtsch Med Wochenschr; 2001 May 25; 126(21):631-7. PubMed ID: 11413752 [No Abstract] [Full Text] [Related]